{
  "id": 5347543,
  "title": "Milestone Pharma Announces Approval Of Etripamil Nasal Spray In China; Triggers Milestone Payment",
  "url": "https://urgent.news/2026/09/03/milestone-pharma-announces-approval-of-etripamil-nasal-spray-in-china",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-09-03T13:57:39.000Z",
  "source": {
    "name": "Nasdaq Markets",
    "slug": "nasdaq-markets",
    "url": "https://www.nasdaq.com/articles/milestone-pharma-announces-approval-etripamil-nasal-spray-china-triggers-milestone-payment"
  },
  "original_language": "en",
  "account": null,
  "summary": "(RTTNews) - Milestone Pharmaceuticals Inc. (MIST) announced that China's National Medical Products Administration has approved etripamil nasal spray for the treatment of paroxysmal supraventricular tachycardia in adults. The NMPA decision marks the first regulatory approval of e",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}